Chemical Structure : AKT1 (E17K) inhibitor compound 4
CAS No.:
2982896-18-2
AKT1 (E17K) inhibitor compound 4
Catalog No.: PC-23916Not For Human Use, Lab Use Only.
AKT1 (E17K) inhibitor compound 4 is a potent, mutant-selective inhibitor of AKT1 (E17K) mutant, potently reduces cell viability of LAPC4-CR cells with EC50 of 9 nM.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Purity & Documentation Purity:
>98% (HPLC)
Biological Activity
AKT1 (E17K) inhibitor compound 4 is a potent, mutant-selective inhibitor of AKT1 (E17K) mutant, potently reduces cell viability of LAPC4-CR cells with EC50 of 9 nM.
Compound 4 binds to AKT1 (E17K) more potently than Compound 3 and shows greater selectivity over WT AKT1 (2.5-fold) and AKT2 (24-fold).
Compound 4 dissociates from purified WT AKT1 18-fold faster than AKT1 (E17K) and shows greater potency towards E17K-mutant LAPC4-CR and HBCx-2 cells relative to SkBr3 and MCF7 cells.
Compound 4 (30 mg /kg, twice-daily) significantly blocked LAPC4-CR tumour growth showed significant, exhibited dose-dependent tumour growth inhibition (75% at 20 mg/kg; 96% at 30 mg/kg) in homozygous E17K-mutant breast cancer model (HBCx-2 patient-derived xenograft), while WT AKT1 breast cancer xenograft model (BT-474) was less sensitive.
Physicochemical Properties
|
M.Wt
|
572.60
|
|
Formula
|
C33H25FN6O3
|
|
Appearance
|
Solid
|
|
CAS No.
|
|
|
Storage
|
- Solide Powder
-
-20°C 12 Months; 4°C 6 Months
|
- In Solvent
-
-80°C 6 Months; -20°C 6 Months
|
|
Shipping
|
|
|
Solubility
|
10 mM in DMSO
|
|
Chemical Name/SMILES
|
N-(4-(2-(2-aminopyridin-3-yl)-5-phenyl-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-2-(2-fluoro-4-formyl-3-hydroxyphenyl)acetamide
|
References
1. Craven GB, et al. Nature. 2025 Jan;637(8044):205-214.
Contact Us
sales@probechem.com
